companydata.dkcompanydata.dk

PHARMA NORD ApS: Financial statements 2014

CVR: 67303016

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

PHARMA NORD ApS (CVR 67303016) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 317,138,255 and a net result of DKK 30,238,194 compared with DKK 11,151,062 the year before. The profit margin was 9.5%. Equity in the 2014 report amounted to DKK 29,760,298. The solvency ratio was 9.1%. The company had 285 employees in the financial year.

Revenue
DKK 317,138,255
Gross Profit
DKK 121,505,249
Profit/Loss
DKK 30,238,194
Equity
DKK 29,760,298
Total Assets
DKK 327,519,891
Employees
285

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014317.1 mio.121.5 mio.30.2 mio.29.8 mio.285
2013317.4 mio.98.7 mio.11.2 mio.-215 t.275

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

PHARMA NORD ApS: The 2013 annual report is outJun 3, 2014

PHARMA NORD ApS has published its annual report for 2013. Revenue came to DKK 317,354,452, and the net result was DKK 11,151,062.

Bent Henriksen leaves the board of PHARMA NORD ApSFeb 12, 2014

As of February 12, 2014, Bent Henriksen has left the board of directors of PHARMA NORD ApS.

About PHARMA NORD ApS

PHARMA NORD ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 1981. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named DANMARKS HELSEKOST DISTRIBUTION ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO I ApS and PharmCo III ApS. The company has 298 employees (2026). In 2025, the company reported revenue of DKK 518,005,000 and a net result of DKK 26,711,000 compared with DKK 32,254,000 the year before. Equity in the 2025 report amounted to DKK 181,417,000.

Source: annual report 2025, Danish Business Authority